View in EDS PDF Full Text

Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.

Saved in:
Bibliographic Details
Title: Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
Authors: van Wilpe S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Simnica D; Department of Internal Medicine IV, Oncology/Haematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., Slootbeek P; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Ee T; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Pamidimarri Naga S; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Gorris MAJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Oncode Institute, Utrecht, The Netherlands., van der Woude LL; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sultan S; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Koornstra RHT; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands., van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands., Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Kroeze LI; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Simons M; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., van Leenders GJLH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Binder M; Department of Internal Medicine IV, Oncology/Haematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany., de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
Source: Oncoimmunology [Oncoimmunology] 2022 Jul 01; Vol. 11 (1), pp. 2094133. Date of Electronic Publication: 2022 Jul 01 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35800157
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Wilpe+S%22">van Wilpe S</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Simnica+D%22">Simnica D</searchLink>; Department of Internal Medicine IV, Oncology/Haematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.<br /><searchLink fieldCode="AU" term="%22Slootbeek+P%22">Slootbeek P</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Ee+T%22">van Ee T</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Pamidimarri+Naga+S%22">Pamidimarri Naga S</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gorris+MAJ%22">Gorris MAJ</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Woude+LL%22">van der Woude LL</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.; Oncode Institute, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sultan+S%22">Sultan S</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Koornstra+RHT%22">Koornstra RHT</searchLink>; Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Oort+IM%22">van Oort IM</searchLink>; Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Gerritsen+WR%22">Gerritsen WR</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kroeze+LI%22">Kroeze LI</searchLink>; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Simons+M%22">Simons M</searchLink>; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Leenders+GJLH%22">van Leenders GJLH</searchLink>; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Binder+M%22">Binder M</searchLink>; Department of Internal Medicine IV, Oncology/Haematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.<br /><searchLink fieldCode="AU" term="%22de+Vries+IJM%22">de Vries IJM</searchLink>; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Mehra+N%22">Mehra N</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2022 Jul 01; Vol. 11 (1), pp. 2094133. <i>Date of Electronic Publication: </i>2022 Jul 01 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35800157
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2022.2094133
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2094133
    Titles:
      – TitleFull: Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Wilpe S
      – PersonEntity:
          Name:
            NameFull: Simnica D
      – PersonEntity:
          Name:
            NameFull: Slootbeek P
      – PersonEntity:
          Name:
            NameFull: van Ee T
      – PersonEntity:
          Name:
            NameFull: Pamidimarri Naga S
      – PersonEntity:
          Name:
            NameFull: Gorris MAJ
      – PersonEntity:
          Name:
            NameFull: van der Woude LL
      – PersonEntity:
          Name:
            NameFull: Sultan S
      – PersonEntity:
          Name:
            NameFull: Koornstra RHT
      – PersonEntity:
          Name:
            NameFull: van Oort IM
      – PersonEntity:
          Name:
            NameFull: Gerritsen WR
      – PersonEntity:
          Name:
            NameFull: Kroeze LI
      – PersonEntity:
          Name:
            NameFull: Simons M
      – PersonEntity:
          Name:
            NameFull: van Leenders GJLH
      – PersonEntity:
          Name:
            NameFull: Binder M
      – PersonEntity:
          Name:
            NameFull: de Vries IJM
      – PersonEntity:
          Name:
            NameFull: Mehra N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2022 Jul 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1